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Abstract
The incidence of cutaneous malignant melanoma continues
to rise in the United States. This deadly disease is potentially
curable if caught at an early stage, however screening
programs remain controversial. The United States Preventive
Services Task Force cites insufficient evidence to recommend
screening, by total-body skin examination (TBSE), for early
detection of cutaneous melanoma. While definitive studies
may be cost-prohibitive in the United States, more recent
evidence suggests that organized programs to increase TBSE
reduce mortality from melanoma. The positive impact of
TBSE, and education regarding risk reduction and skin selfexamination, is most likely to be cost-effective in high-risk
patients such as middle-aged and older men. This population
also includes those with changing moles or those who always
or usually sunburn; those with melanoma in a first-degree
relative, or dysplastic nevi or extensive moles; and those
with high-risk ultraviolet (UV) exposure or other risk factors.
The role of new technology, such as in-office and in-home
dermoscopy, continues to evolve. Primary care clinicians are
challenged in everyday practice to appropriately prioritize
TBSE and empower their patients for “skin awareness” and
self-detection of melanoma. (J Patient-Centered Res Rev.
2014;1(1):33-40.)

Table 1. Melanoma Incidence Facts
Overall lifetime risk in USA is 2%3
2% of all melanoma cases occur in those < 20 years old1
Overall, incidence and mortality rates are greater in men
than women3
Between ages of 15 and 39, increase in incidence has
been greater in women3
Most common cause of cancer in women ages 25-29;
second only to breast cancer in women ages 30-341
Incidence rates in white persons are 7-25 times higher
than persons of non-white race1,3
Of race/gender groups, highest (and increasing) incidence
rates are in middle-aged and older white males1-5

Table 1 provides additional detail regarding melanoma
incidence.
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Overall, melanoma is most likely to occur in women on the
lower extremities. In men, the trunk is the most common site
of involvement; followed by the upper extremities.3 Reasons
for these differences are unclear.
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Etiology and Risk Factors

Introduction
Cutaneous malignant melanoma is responsible for 75%
of all skin cancer deaths, yet represents only 3-5% of all
skin cancers.1 Each year, over 75,000 cases of melanoma
are diagnosed in the United States, and approximately
9,000 individuals will die of this disease. The incidence of
melanoma has been on the rise for decades, and the annual
incidence rate has increased over 15-fold since the 1930s.2-5
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The etiology of the malignant transformation of melanocytes
which leads to melanoma is multi-factorial and not fully
understood. It includes ultraviolet (UV) radiation and genetic
predisposition.1 The p53 suppressor gene is often mutated in
melanoma. It is directly affected by UV radiation, especially
UV-B. Solar UV exposure directly damages cells and
molecules, including DNA, proteins and lipids. This leads to
photoaging, immunosuppression and photocarcinogenesis.5
Risk factors for melanoma are summarized in Table 2.
Melanoma risk is increased with the use of UV-emitting
tanning devices, especially before age 35.3,5 The recent
overall increase in skin cancer in younger women may be
secondary to indoor tanning.3 Interestingly, one survey of
Aurora.org/Journal
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Table 2. Melanoma Risk Factors1,3,6

Fair skin and hair

is being uninsured or on Medicaid, as opposed to private
insurance.3 Among non-Hispanic whites, declines in
melanoma mortality rates in recent decades have largely
occurred in the more educated groups of individuals.10

Being more likely to sunburn rather than tan

The Screening Controversy

Older age

Greater than 20 moles
Freckling
Three or more atypical moles
Immunosuppression
Previous psoralen Ultraviolet-A (PUVA) treatment
Previous squamous cell carcinoma
Solar keratoses
Xeroderma pigmentosum
A family history of melanoma (particularly first-degree
relatives) or dysplastic nevi
Other significant UV exposures

inner city Brooklyn, New York, college students (41% white)
found an association between watching reality television
beauty shows and outdoor tanning and tanning lamp use.7
In the United States, age-adjusted rates of early- and latestage melanoma are both significantly higher in counties
with high solar UV exposure than in those with lower solar
UV exposure.8 Similarly, in Australia, the country with
the highest melanoma incidence rates (twice that of the
United States),3 melanoma incidence rates are highest in the
northern, more tropical areas of the continent.9
Higher socioeconomic status has been associated with
increased melanoma incidence but decreased mortality
rates among those with melanoma.2 In the United States and
other developed countries, the increased incidence in those
of higher socioeconomic status appears to be related to the
higher incidence of Northern European ancestry within this
section of society (fair hair and skin, likelihood to burn,
rather than tan, increased freckling and atypical moles),
and greater leisure-time sun exposure, rather than income.3,5
Females in this group are more likely to engage in indoor
tanning activities than those of lower socioeconomic status.
Lower socioeconomic status is related to having a more
advanced stage of melanoma at the time of diagnosis, as
34
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In 2001, the United States Preventive Services Task Force
(USPSTF) concluded that there was insufficient evidence
to recommend for or against screening, by total-body
skin examination (TBSE) for early detection of cutaneous
melanoma, or squamous cell or basal cell carcinoma.11 A
2009 update of this recommendation acknowledged gaps
in the relevant research literature, but again concluded that
direct evidence to support the benefits of physician or patient
screening skin examinations to reduce morbidity or mortality
from skin cancer was lacking.12 This occurred despite the
authors acknowledging that physician-discovered melanoma
was at an earlier stage (thinner) than non-physician detection
(see below), and limited evidence from one study13 of
reduction of melanoma morbidity and mortality by skin selfexamination (SSE).
The American Cancer Society (ACS), however, endorses
TBSE and monthly SSE. In addition, many researchers
and clinicians are uncomfortable with the notion of not
recommending some form of screening for the early detection
of melanoma. Curiel-Lewandrowski and colleagues
emphasize that there are several recent studies which support
the potential benefit of screening for melanoma.14 Mitchell
and Leslie opine that “we have failed to make significant
gains in mortality (from melanoma) during the past 20 years
because we have not empowered our society with the basic,
crucial knowledge to detect disease earlier.”15 Wolf et al.
suggest targeted screening of aging patients.2
The issue of screening for melanoma remains controversial
to this moment, as illustrated by two publications released
in late summer of 2013. Geller et al. report recent statistics
from Connecticut, the site of the oldest population-based
cancer registry in the United States.16 Noting “unremitting
increases in incidence and mortality of melanoma,” beyond
that expected from increased reporting, the authors call
for large programs of primary prevention and screening of
high-risk populations for melanoma in the United States.
Just several days prior, Esserman and colleagues placed
melanoma screening in the category of that which “expands
the population of indolent tumors, with little or no effect on
the small population of more aggressive tumors.”17
Guided by these recent narrative reviews and original
Reviews

research, let us examine the evidence which would favor
some form of screening for melanoma in the primary care
setting.

Recent Evidence Regarding Screening
It has long been known,4,14,15 and recently reaffirmed,18 that
detection of thinner (earlier) melanoma lesions reduces
mortality, and if detected early enough, melanoma is
potentially curable in all patients.4 Swetter et al. studied 566
adult invasive melanoma patients of clinics in California
and Michigan using survey methodology.19 Thinner tumors
(≤ 1 mm) were associated with younger age, female gender,
higher education level, and physician discovery. Physician
TBSE was associated with thinner tumors, largely due to the
effect of this examination in men over 60 years old. Patients
who used a melanoma picture as a visual aid (provided by
the study) and performed their own TBSE were more likely
to have thinner tumors. The authors concluded that physician
and patient TBSE were complementary early detection
strategies, particularly in men over 60. They further suggested
that physician TBSE may be the more practical approach
for early detection in the high-risk group of older men.19 A
community-based, case-control telephone survey study of
3,762 cases and 3,824 controls in Queensland, Australia,
associated TBSE in the three years before diagnosis with a
14% lower risk of being diagnosed with a thick melanoma
(>0.75 mm).20
Additional studies from this area of Australia yield
statistics regarding melanoma screening. Data from
16,383 TBSEs of patients in a centrally-organized program
of skin screening clinics staffed by trained primary care
physicians, with all patients having suspect lesions being
referred to their own physician for further treatment,21
includes: 1) a total of 2,302 referrals were made for 4,129
suspect lesions, and 2) data from 95% of the 1,417 lesions
which were excised included a yield of 33 melanomas (0.2%
of all TBSEs), 252 basal cell carcinomas and 97 squamous
cell carcinomas. The calculated specificity of TBSE for
melanoma was 86% (which the authors suggest is comparable
to that of other screening tests such as mammography).
The sensitivity of TBSE for melanoma was not calculated,
as follow-up of those who had a negative TBSE was not
conducted.21 A related study collected data on 28,755 skin
examinations (resulting in 11,403 excisions or biopsies)
from random samples of family medicine physicians
excising or performing biopsy of skin lesions of patients in
their routine practice, and from family physicians working in
the aforementioned centrally-organized skin screening
clinics.22 The number (of pigmented lesions) needing
Reviews

to be excised (NNE) to find one melanoma was 19.6, a
number that was significantly higher if there was strong
patient pressure to excise the lesion, and significantly
lower if the physician thought the lesion was likely to be
malignant. The authors admit that determining an ideal
number needed to excise is difficult given the risk of
missing melanoma versus the need to reduce health care
costs.22 It may be noted that the NNE generally varies from
20-40 for primary care clinicians in non-specialized
clinics, and 4-18 for dermatologists at specialty clinics.23 A
multinational, multicenter prospective trial recruited 14,381
subjects from all willing adult patients seeking dermatology
consultation for focused skin lesions. As a result, a TBSE
was initiated for each participant and suspicious or equivocal
lesions were excised or biopsied. Melanoma was detected in
40 subjects (0.3%), and nonmelanoma skin cancer in 299
(2.1%).24 In this study, 47 patients needed to be examined
by TBSE to find one skin malignancy, and 400 patients
examined to detect one melanoma. The authors calculated
the risk of missing one malignancy if not performing TBSE
at 2.2%.
The aforementioned investigations suggest that melanoma
screening would likely result in these skin cancers being
found at an earlier stage, and provide approximate figures
for the sensitivity, specificity and NNE regarding such
screening. These studies, like most all such studies in the
past,2 do not address whether or not these efforts would
save lives or be cost effective. A community-based study
of melanoma screening was undertaken in a population of
560,000 persons in Queensland, Australia. The study was
designed to detect a 20% reduction in melanoma mortality
rates during a 15-year period. The trial, however, could not
be completed due to the significant cost of the program.14,25
A compelling, 2003-2004 population-based skin cancer
screening project included 360,288 adults 20 years or older
in an area of Germany.26 Subjects were initially screened by
TBSE with a generalist physician. If suspicious lesions were
identified, the individual was referred to a dermatologist for
a second examination. Trends in melanoma mortality rates in
this area were compared to adjacent regions and other parts
of Germany. At a 5-year follow-up, the melanoma mortality
rate declined by 47% in men and by 49% in women in this
region of the country, while mortality rates were stable in
the other areas. The authors of the update of the USPSTF
recommendations point out that an adequately powered,
population-based randomized controlled trial of screening
in the United States would require approximately 800,000
subjects in order to demonstrate favorable mortality outcomes
of screening for skin cancer.12 Such a trial is unlikely to be
Aurora.org/Journal
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clinician using the unaided eye generally involves either the
use of the ABCDE mnemonic, or the “ugly duckling sign.”1
The ABCDE mnemonic involves systematic examination
of lesions for the presence of asymmetry (A), irregular or
ill-defined border (B), variation in color from one area of the
same lesion to another (C), diameter larger than 6 mm (D),
and if the mole is evolving (changing in size, shape or color)
or looks different than surrounding moles (E). The latter
statement of the “E” portion of the mnemonic is the concept
of the easily taught method of the “ugly duckling sign” which
is to identify and investigate the mole which looks different
than surrounding moles. In addition, depigmentation,
ulceration and bleeding within a melanocytic lesion suggest
the presence of malignant melanoma.27 For illustration,
Figure 1 includes examples of cutaneous melanoma, and
Figure 2 presents examples of skin lesions which may
resemble melanoma. Melanoma may also occur in the
nail apparatus as new pigmented lines on a single nail or
dyspigmentation of the nail bed or nailfold.1,27 Comprehensive
TBSE includes not only skin surfaces, but nail beds, palms,
soles and mucocutaneous surfaces (e.g. careful visual
inspection of the vulvar and vaginal mucosa during a pelvic
examination). The reader is referred to a recent publication,1
and a variety of available dermatologic atlases for further
details and color pictures to aid in melanoma screening.

1A

1B

Total-body photography may be useful for documentation
and for follow-up of patients being screened in the office for
melanoma.27 The cost-effectiveness of this strategy has not
been determined.

1C

Figure 1. Examples of melanoma lesions. All three lesions
exhibit uneven color and irregular borders. [Photographs
courtesy of National Cancer Institute (http://www.cancer.gov).]

undertaken given the tremendous cost. Older models of costeffectiveness suggest that screening programs for melanoma
may be comparable to that of other cancer screening programs
currently in place in the United States in this regard.2,4,14,15

Screening Methods
Screening for melanoma during a TBSE by a primary care
36
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One concern is that while Americans make an average of
1-2 visits to primary care physicians each year, these
clinicians may not be adequately trained to identify early
melanoma.14 A recent systematic review revealed that while
many specific educational interventions have been developed
for primary care physician skin cancer education, including
one aimed at medical students on a primary care rotation,28
there is variability in the particular interventions and the
design to study them. Few have been rigorously evaluated.29
Overall rates of TBSE remain low in the United States, and
disparities regarding screening remain for Hispanics, nonwhite racial groups and those with less education or lower
health literacy.30
Dermoscopy (several synonyms) is a hand-held, noninvasive,
real-time imaging technique to aid in the detection of skin
cancer, including melanoma. It is available, with training,
for use by primary care physicians.31 In the hands of
dermatologists, this technique has been shown to increase
Reviews

sensitivity and specificity of skin cancer diagnosis, and
decrease the NNE, compared to the naked eye.23 Primary
care physicians also increase their sensitivity for detecting
melanoma with the use of this technology.1,27 Argenziano
and colleagues have suggested that dermoscopy improves
melanoma recognition. Signs of malignancy in melanoma
become visible with dermoscopy much sooner than with the
naked eye (the ABC portion of the ABCDE criteria become
more evident only when the melanoma is relatively large).
In addition, clinicians may more closely examine the more
benign looking lesions if dermoscopy is available, and use
this technique to monitor their patients.23
Available dermoscopic techniques include contact or
noncontact dermoscopy with or without a liquid interface.
Direct contact and the liquid interface provide maximum
image clarity. Descriptions of the technical aspects of this
procedure are readily available.27,31 The reader is referred to
the very recent publication of Marghoob et al. for excellent
pictorial descriptions.31 A large study of dermatologists
performing this procedure in pigmented skin lesion clinics
revealed that the time needed for TBSE was 70 seconds
without dermoscopy and 142 seconds with dermoscopy.32
Earlier studies have shown that self-skin examination (SSE),
often in conjunction with public educational campaigns,
has resulted in earlier presentation and thinner melanoma
lesions upon presentation.14,15,19 In the aforementioned study
by Swetter et al., most melanoma lesions were discovered by
SSE, rather than a physician, with important contributions by
family and friends. Thinner lesions, however, were associated
with physician diagnosis.19 In that study, a combination of
regular SSE and a melanoma visual aid were associated
with thinner tumors. A randomized trial of Rhode Island
and Massachusetts residents from 2000 to 2001, observed a
49% increase in SSE at one year in the intervention group.
Helpful interventions included a video, a hand mirror, a
shower card, brochures and sample photographs, as well as a
health educator.33 In an Australian study of men over 50, the
addition of a video or DVD to written materials had only a
transient advantage for optimization of SSE.34
Recently, new technology for patient-assisted melanoma
detection has become available to consumers. Dermoscope
attachments are now available for mobile telephones,
allowing the consumer to send images electronically to a
teledermatologist. The feasibility of this technology was
demonstrated in 10 patients in Australia.35 Currently these
items are available for approximately $450. No outcomes
data regarding their use has been published. A number of other
Reviews

2A

Figure 2.
Nonmalignant pigmented
skin lesions variably
resembling melanoma.
Lesion 2A is a dysplastic
nevus. Lesions 2B and
2C are common moles.
[Photographs courtesy of
National Cancer Institute
(http://www.cancer.gov).]

2B

2C

smart phone applications are available. The performance of
the software appears to be highly variable.36

A Few Words Regarding Biopsy
Any suspicious lesion encountered by a primary care
clinician should be biopsied, after carefully documenting the
appearance and the dimensions of the lesion in the medical
record.1 The preferred method of excision for diagnosis of a
lesion suspected to be melanoma involves complete removal
of the lesion, generally with the use of an elliptical incision
made with a scalpel. Margins of normal-appearing skin
should be 1-3 mm peripheral to the lesion, and a deep margin
of subcutaneous fat, including appendageal structures.
Punch biopsies for excision may also be used if the entire
pigmented lesion, with margin, will fit entirely within
the trephine.27 While use of deep scoop or shave biopsies
(saucerization) may be appropriate in some instances, the
use of superficial shave biopsies are not recommended when
invasive melanoma is suspected.1,27 The reader is referred to
Aurora.org/Journal
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the excellent review by Tran et al., for details regarding the
biopsy of pigmented lesions, including those of the nails.27

Community Empowerment
Finally, an additional important strategy is for primary care
clinicians to empower their panel of patients to prevent
and help diagnose melanoma. Mitchell and Leslie, in their
recent review,15 suggest that primary prevention messages
(principally focused on sun avoidance) have been an overemphasized component of melanoma outreach education.
While not recommending abandonment of such efforts,
they point out that even in intensive campaigns, long-term
behavioral changes have been very difficult to sustain.
Primary care clinicians may be able to make an impact by
inducing their high risk patients to have “skin-awareness.”
Patients may be referred to the ACS website as it contains
excellent information for patients, including instructions
on SSE: http://www.cancer.org/acs/groups/cid/documents/
webcontent/003184-pdf.pdf.
While more than half of all melanomas may be detected
by patients, those individuals at highest risk for melanoma
may be those least likely to seek skin cancer screening.2
For example, women are more likely to detect melanomas
in both themselves and their spouses. Yet some high-risk
individuals do apparently recognize their personal risk
factors and notice suspicious lesions.4 For several years it
has been suggested that educational outreach to encourage
SSE for melanoma be targeted toward middle-aged and
older men, particularly those with changing moles or skin
types I and II (those who always or usually sunburn).4,15 In
addition, some suggest that any clinician TBSE include SSE
education.15 The latter authors point out that the USPSTF
does not recommend routine physician or patient breast
examination, yet a significant majority of both groups of
individuals perform them.15 They further herald “causerelated marketing” such as breast cancer awareness, and
basically suggest the need for a slogan and a symbol to aid
in melanoma outreach education to high-risk individuals.

not likely to improve. The successful provision of preventive
screenings and education during a primary care office visit
is complex and includes patient, physician, relationship and
visit contextual factors, such as the number of problems
brought to the fore by the patient at that encounter.38
As seen above, TBSE at a routine office visit likely adds
70 or more seconds,32 and the education associated with it
perhaps another minute. The challenge for the primary care
clinician, given the constraints of limited office visit time
and resources, is to effectively and individually prioritize
interventions and screenings that would most improve the
future health of a particular patient at that time.
It would seem prudent, based on what we have learned, to
empower patients to have “skin awareness” and report
suspicious findings, and to perform TBSE and teach SSE to
high-risk patients. The latter would include middle-aged and
older men, persons of all ages who are at risk due to skin type
and behavior such as the use of tanning beds, those with a
first-degree relative with melanoma, and other individuals
at risk or who are concerned about their skin. It may also
be appropriate, based on the clinician’s relationship with a
particular patient and perceived receptivity to advice, to offer
primary skin protection such as sun avoidance. An algorithm
based on these considerations is found in Figure 3.

Conclusion
Cutaneous malignant melanoma incidence is increasing in
the United States. It is associated with significant morbidity
and mortality, but is potentially curable if found at an early
stage. Despite lack of recommendation from the USPSTF,
and current controversy, recent evidence has suggested that
primary care clinicians, who are entrusted with the overall
health and well-being of their patients, strongly consider
targeted in-office screening, and education regarding home
skin surveillance, of their high-risk patients. All suspicious
lesions should be subjected to adequate biopsy.

Conflicts of Interest
None.

Synthesis
As discussed above, definitive clinical outcomes and cost
effectiveness studies regarding the wisdom of screening
populations of patients in the United States for melanoma may
never be forthcoming. Once the examination room door closes,
however, the overall health and well-being of that particular
patient is of immediate importance to the practicing primary
care clinician. Lack of adequate time with patients at office
encounters is a perceived barrier to provision of “high-quality
medical care” in the primary care setting,37 and this situation is
38
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Figure 3. Suggested Algorithm for Primary Care Office Screening and Prevention of Cutaneous Malignant Melanoma

General Counseling Regarding
UV Radiation Avoidance and Protection and Skin Awareness
Patient Characteristics
• > 50 years old, particularly male
• Skin that burns easily
• Any prior skin cancer or solar keratoses
• Family history of melanoma
• > 20 moles
• Atypical nevi
• Chronic immunosuppression
• Indoor tanning or high intensity sun exposure
• Concern about skin lesion(s)

Yes

No

Teach and perform TBSE, with or
without dermoscopy. Use ABCDE
mnemonic, “ugly duckling” sign

High-risk Behavior:
High intensity sun exposure
Indoor tanning

Suspicious Lesion

Yes

No

Yes

No

Biopsy or refer

SSE and interval
clinician TBSE

Intense
counseling
regarding
UV radiation
avoidance and
protection and
skin awareness

Skin
awareness

TBSE = total-body skin examination
SSE = self-skin examination
ABCDE mnemonic and “ugly duckling” sign = see article text
Flow chart developed, in part, from content of references 1,3,5,6,15
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